NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression
- Autores
- Bender, Crhistian Luis; Yang, Qian; Sun, Lu; Liu, Siqiong June
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Neuronal activity can alter the phosphorylation state of eukaryotic elongation factor 2 (eEF2) and thereby regulates protein synthesis. This is thought to be the underlying mechanism for a form of synaptic plasticity that involves changes in the expression of synaptic AMPA type glutamate receptors. Phosphorylation of eEF2 by Ca/calmodulin-dependent eEF2 kinase reduces the activity of eEF2, and this is prevented by a commonly used eEF2 kinase inhibitor, NH125. Here we show that 10 μM NH125 increased the expression of synaptic GluA2-containing receptors in mouse cerebellar stellate cells and this was prevented by a protein synthesis inhibitor. However NH125 at 10 μM also reduced the level of CPEB3, a protein that is known to bind to GluA2 mRNA and suppress GluA2 (also known as GluR2) synthesis. In contrast, a low concentration of NH125 lowered the peEF2 level, but did not alter CPEB3 expression and also failed to increase synaptic GluA2 receptors. A selective eEF2 kinase inhibitor, A-484954, decreased the level of peEF2, without changing the expression of CPEB3. This suggests that reducing peEF2 does not lead to a decrease in CPEB3 levels and is not sufficient to increase GluA2 synthesis. Thus NH125 at 10 μM reduced the level of CPEB3, and promoted GluA2 translation via a mechanism independent of inhibition of eEF2 kinase. Therefore NH125 does not always alter protein synthesis via selective inhibition of eEF2 kinase and the effects of NH125 on translation of mRNAs should be interpreted with caution.
Fil: Bender, Crhistian Luis. Louisiana State University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Yang, Qian. Louisiana State University; Estados Unidos
Fil: Sun, Lu. Louisiana State University; Estados Unidos
Fil: Liu, Siqiong June. Louisiana State University; Estados Unidos - Materia
-
Ampa Receptors
Cerebellum
Cpeb3
Eef2
Eef2 Kinase
Glua2
Interneurons
Nh125
Protein Synthesis - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/50102
Ver los metadatos del registro completo
id |
CONICETDig_46fc142602aa1f4e34182550044fdc74 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/50102 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expressionBender, Crhistian LuisYang, QianSun, LuLiu, Siqiong JuneAmpa ReceptorsCerebellumCpeb3Eef2Eef2 KinaseGlua2InterneuronsNh125Protein Synthesishttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Neuronal activity can alter the phosphorylation state of eukaryotic elongation factor 2 (eEF2) and thereby regulates protein synthesis. This is thought to be the underlying mechanism for a form of synaptic plasticity that involves changes in the expression of synaptic AMPA type glutamate receptors. Phosphorylation of eEF2 by Ca/calmodulin-dependent eEF2 kinase reduces the activity of eEF2, and this is prevented by a commonly used eEF2 kinase inhibitor, NH125. Here we show that 10 μM NH125 increased the expression of synaptic GluA2-containing receptors in mouse cerebellar stellate cells and this was prevented by a protein synthesis inhibitor. However NH125 at 10 μM also reduced the level of CPEB3, a protein that is known to bind to GluA2 mRNA and suppress GluA2 (also known as GluR2) synthesis. In contrast, a low concentration of NH125 lowered the peEF2 level, but did not alter CPEB3 expression and also failed to increase synaptic GluA2 receptors. A selective eEF2 kinase inhibitor, A-484954, decreased the level of peEF2, without changing the expression of CPEB3. This suggests that reducing peEF2 does not lead to a decrease in CPEB3 levels and is not sufficient to increase GluA2 synthesis. Thus NH125 at 10 μM reduced the level of CPEB3, and promoted GluA2 translation via a mechanism independent of inhibition of eEF2 kinase. Therefore NH125 does not always alter protein synthesis via selective inhibition of eEF2 kinase and the effects of NH125 on translation of mRNAs should be interpreted with caution.Fil: Bender, Crhistian Luis. Louisiana State University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Yang, Qian. Louisiana State University; Estados UnidosFil: Sun, Lu. Louisiana State University; Estados UnidosFil: Liu, Siqiong June. Louisiana State University; Estados UnidosPergamon-Elsevier Science Ltd2016-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/50102Bender, Crhistian Luis; Yang, Qian; Sun, Lu; Liu, Siqiong June; NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression; Pergamon-Elsevier Science Ltd; Neuropharmacology; 101; 2-2016; 531-5370028-3908CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.neuropharm.2015.03.017info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0028390815001094info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-17T10:44:30Zoai:ri.conicet.gov.ar:11336/50102instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-17 10:44:31.1CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression |
title |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression |
spellingShingle |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression Bender, Crhistian Luis Ampa Receptors Cerebellum Cpeb3 Eef2 Eef2 Kinase Glua2 Interneurons Nh125 Protein Synthesis |
title_short |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression |
title_full |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression |
title_fullStr |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression |
title_full_unstemmed |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression |
title_sort |
NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression |
dc.creator.none.fl_str_mv |
Bender, Crhistian Luis Yang, Qian Sun, Lu Liu, Siqiong June |
author |
Bender, Crhistian Luis |
author_facet |
Bender, Crhistian Luis Yang, Qian Sun, Lu Liu, Siqiong June |
author_role |
author |
author2 |
Yang, Qian Sun, Lu Liu, Siqiong June |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
Ampa Receptors Cerebellum Cpeb3 Eef2 Eef2 Kinase Glua2 Interneurons Nh125 Protein Synthesis |
topic |
Ampa Receptors Cerebellum Cpeb3 Eef2 Eef2 Kinase Glua2 Interneurons Nh125 Protein Synthesis |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Neuronal activity can alter the phosphorylation state of eukaryotic elongation factor 2 (eEF2) and thereby regulates protein synthesis. This is thought to be the underlying mechanism for a form of synaptic plasticity that involves changes in the expression of synaptic AMPA type glutamate receptors. Phosphorylation of eEF2 by Ca/calmodulin-dependent eEF2 kinase reduces the activity of eEF2, and this is prevented by a commonly used eEF2 kinase inhibitor, NH125. Here we show that 10 μM NH125 increased the expression of synaptic GluA2-containing receptors in mouse cerebellar stellate cells and this was prevented by a protein synthesis inhibitor. However NH125 at 10 μM also reduced the level of CPEB3, a protein that is known to bind to GluA2 mRNA and suppress GluA2 (also known as GluR2) synthesis. In contrast, a low concentration of NH125 lowered the peEF2 level, but did not alter CPEB3 expression and also failed to increase synaptic GluA2 receptors. A selective eEF2 kinase inhibitor, A-484954, decreased the level of peEF2, without changing the expression of CPEB3. This suggests that reducing peEF2 does not lead to a decrease in CPEB3 levels and is not sufficient to increase GluA2 synthesis. Thus NH125 at 10 μM reduced the level of CPEB3, and promoted GluA2 translation via a mechanism independent of inhibition of eEF2 kinase. Therefore NH125 does not always alter protein synthesis via selective inhibition of eEF2 kinase and the effects of NH125 on translation of mRNAs should be interpreted with caution. Fil: Bender, Crhistian Luis. Louisiana State University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Yang, Qian. Louisiana State University; Estados Unidos Fil: Sun, Lu. Louisiana State University; Estados Unidos Fil: Liu, Siqiong June. Louisiana State University; Estados Unidos |
description |
Neuronal activity can alter the phosphorylation state of eukaryotic elongation factor 2 (eEF2) and thereby regulates protein synthesis. This is thought to be the underlying mechanism for a form of synaptic plasticity that involves changes in the expression of synaptic AMPA type glutamate receptors. Phosphorylation of eEF2 by Ca/calmodulin-dependent eEF2 kinase reduces the activity of eEF2, and this is prevented by a commonly used eEF2 kinase inhibitor, NH125. Here we show that 10 μM NH125 increased the expression of synaptic GluA2-containing receptors in mouse cerebellar stellate cells and this was prevented by a protein synthesis inhibitor. However NH125 at 10 μM also reduced the level of CPEB3, a protein that is known to bind to GluA2 mRNA and suppress GluA2 (also known as GluR2) synthesis. In contrast, a low concentration of NH125 lowered the peEF2 level, but did not alter CPEB3 expression and also failed to increase synaptic GluA2 receptors. A selective eEF2 kinase inhibitor, A-484954, decreased the level of peEF2, without changing the expression of CPEB3. This suggests that reducing peEF2 does not lead to a decrease in CPEB3 levels and is not sufficient to increase GluA2 synthesis. Thus NH125 at 10 μM reduced the level of CPEB3, and promoted GluA2 translation via a mechanism independent of inhibition of eEF2 kinase. Therefore NH125 does not always alter protein synthesis via selective inhibition of eEF2 kinase and the effects of NH125 on translation of mRNAs should be interpreted with caution. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-02 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/50102 Bender, Crhistian Luis; Yang, Qian; Sun, Lu; Liu, Siqiong June; NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression; Pergamon-Elsevier Science Ltd; Neuropharmacology; 101; 2-2016; 531-537 0028-3908 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/50102 |
identifier_str_mv |
Bender, Crhistian Luis; Yang, Qian; Sun, Lu; Liu, Siqiong June; NH125 reduces the level of CPEB3, an RNA binding protein, to promote synaptic GluA2 expression; Pergamon-Elsevier Science Ltd; Neuropharmacology; 101; 2-2016; 531-537 0028-3908 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.neuropharm.2015.03.017 info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0028390815001094 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1843605975337009152 |
score |
13.001348 |